Biofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call Transcript

Bruce Jackson: Okay. And then, last question for me. Sometimes the timing of the price increases can have an impact on the calendarization of the quarter. So, what would be looking for this year? Would it be similar to 2023 or might there be any differences?

Fred Leffler: We’re still evaluating our pricing strategy and things like that. We haven’t made a concrete decision on any price increases yet for 2024.

Bruce Jackson: So, in terms of like the seasonality of the revenue by quarter then, can we assume it looks similar to 2023?

Fred Leffler: Yes. I think that’s a good working assumption, and if any changes come to that, we will certainly update everyone.

Bruce Jackson: Okay. Great. Thank you very much.

Hermann Luebbert: Thank you, Bruce.

Fred Leffler: Thank you.

Operator: This concludes our question-and-answer session. I would like to turn the conference back over to management for any closing remarks.

Hermann Luebbert: So, we believe that we had a very successful year in 2023 that we had some transformational changes to the company that makes the status of the company and future of the company look much brighter than what we were looking at a year ago. And with that, I would like to thank all our employees again to taking the company to where we are now. And thank you for taking the time to listen in. Thank you.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.